Product image of Glucose B. Braun Melsunge (Glucose Monohydrate) supplied by GNH India

Glucose B. Braun Melsunge

Active Ingredient:
Glucose Monohydrate
Origin:
EU

Glucose B. Braun Melsunge (Glucose Monohydrate)

Glucose B. Braun Melsunge is an intravenous solution for injection that contains glucose monohydrate as its active ingredient. It is supplied as a sterile liquid formulation intended for infusion, providing a source of carbohydrate energy. The product is manufactured in the European Union and is used in clinical settings where rapid glucose delivery is required.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucose B. Braun Melsunge is employed in a variety of medical situations where intravenous carbohydrate supplementation is needed. It supports patients who cannot obtain adequate nutrition orally or enterally.

  • Treatment of hypoglycemia when oral glucose is not feasible.
  • Provision of calories during peri‑operative fasting.
  • Maintenance of blood glucose levels in critically ill patients.
  • Dilution and carrier for certain intravenous medications.
  • Support for patients receiving parenteral nutrition.

Side Effects

Glucose B. Braun Melsunge may cause a range of reactions, most of which are related to the rapid infusion of a carbohydrate solution.

Common

  • Mild hyperglycemia that resolves with monitoring.
  • Transient nausea or vomiting during infusion.
  • Local irritation or redness at the infusion site.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Allergic reaction such as urticaria, rash, or anaphylaxis.
  • Electrolyte imbalance, particularly hyponatremia, due to large fluid volumes.

Precautions & Warnings

When using Glucose B. Braun Melsunge, clinicians should consider several safety factors to minimize risk. Proper assessment and monitoring are essential.

  • Verify patient’s blood glucose level before and during infusion.
  • Adjust infusion rate in patients with diabetes or impaired glucose tolerance.
  • Monitor fluid balance to avoid overload, especially in heart‑failure patients.
  • Use aseptic technique to prevent contamination of the solution.
  • Assess for signs of allergic reaction during the first administration.
  • Consider electrolyte status, particularly sodium and potassium, before large‑volume infusion.

Avoid Interactions

Glucose B. Braun Melsunge can influence the effects of other medications and should be administered with awareness of potential interactions.

Avoid

  • Concurrent use of high‑dose insulin without appropriate glucose monitoring.
  • Co‑administration with medications that cause hypoglycemia, such as sulfonylureas, without dose adjustment.

Use with caution

  • Beta‑blockers, which may mask hypoglycemia symptoms.
  • Diuretics that affect electrolyte balance.
  • Corticosteroids, which can increase blood glucose levels.
  • Certain cardiac drugs that may be sensitive to fluid shifts.

Frequently Asked Questions

The active ingredient is glucose monohydrate, a simple carbohydrate used for intravenous energy delivery.

It is commonly used to treat hypoglycemia, provide calories during fasting periods, support parenteral nutrition, and serve as a diluent for certain IV medications.

The product is supplied as a sterile solution for injection and is given intravenously, usually through a peripheral or central line.

Yes, but blood glucose levels should be closely monitored and infusion rates adjusted to avoid hyperglycemia.

Common side effects include mild hyperglycemia, transient nausea, and local irritation at the infusion site.

Serious reactions can include severe hyperglycemia, allergic responses such as rash or anaphylaxis, and electrolyte disturbances.

Yes, fluid overload risk is higher in heart‑failure patients, so the infusion rate and total volume should be carefully controlled.

High‑dose insulin and other hypoglycemic agents should be avoided without appropriate glucose monitoring.

Regular checks of blood glucose, electrolytes, and fluid balance are recommended throughout the infusion.

The product can be used in pediatric care, but dosing and infusion rates must be determined by a qualified healthcare professional.

Store the unopened vials or bags according to the manufacturer’s instructions, typically in a cool, dry place away from direct sunlight.

Yes, it can serve as a diluent for certain medications, but compatibility should be confirmed before mixing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.